SomnoMed Limited
SOMNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $136 | $33 | $34 | $69 |
| - Cash | $17 | $18 | $16 | $13 |
| + Debt | $8 | $6 | $7 | $19 |
| Enterprise Value | $126 | $21 | $25 | $75 |
| Revenue | $58 | $54 | $47 | $45 |
| % Growth | 7.6% | 15.4% | 3.2% | – |
| Gross Profit | $34 | $33 | $24 | $25 |
| % Margin | 58.2% | 61.6% | 52% | 54.6% |
| EBITDA | -$1 | $3 | -$2 | -$1 |
| % Margin | -2.6% | 5.7% | -3.5% | -2.5% |
| Net Income | -$3 | -$0 | -$6 | -$6 |
| % Margin | -5.8% | -0.2% | -12.7% | -14.1% |
| EPS Diluted | -0.016 | -0.001 | -0.049 | -0.053 |
| % Growth | -1,644.4% | 98.2% | 7% | – |
| Operating Cash Flow | $4 | $4 | -$2 | -$5 |
| Capital Expenditures | -$2 | -$1 | -$1 | -$2 |
| Free Cash Flow | $2 | $3 | -$3 | -$7 |